BioCentury | Feb 27, 2012
Finance

Cashing in on Qnexa

...strong growth in sales of generics as a result of its November 2010 acquisition of Qualitest Pharmaceuticals...
...from generics rose 131% to $151M and were driven by Endo's November 2010 acquisition of Qualitest Pharmaceuticals...
BioCentury | Oct 31, 2011
Finance

Finding love in Russia

...3Q10. Sales from generics rose 439% to $148M and were driven by the acquisition of Qualitest Pharmaceuticals...
BioCentury | Mar 7, 2011
Analyst Picks & Changes

Analyst picks & changes

...He believes the revenue increase largely is driven by the recent acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Feb 21, 2011
Strategy

Sweet Spot revisited

...Holdings Inc. sold $400 million in notes to help fund its acquisition of generics play Qualitest Pharmaceuticals...
BioCentury | Dec 6, 2010
Company News

Endo, Qualitest Pharmaceuticals deal

...billion in cash (see BioCentury, Oct. 4). Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP), Chadds Ford, Pa. Qualitest Pharmaceuticals...
BioCentury | Nov 22, 2010
Finance

Regulatory Milestones

...The company plans to use the proceeds to partially finance its acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Nov 20, 2010
Financial News

Endo raises $400M in note deal

...The company plans to use the proceeds to partially finance its acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Nov 16, 2010
Financial News

Endo planning $400M note deal

...company plans to use the proceeds to partially finance its ongoing acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Oct 4, 2010
Company News

Endo Pharmaceuticals Holding Inc., Qualitest Pharmaceuticals deal

...advised Endo and J.P. Morgan advised Qualitest. Endo Pharmaceuticals Holding Inc. (NASDAQ:ENDP), Chadds Ford, Pa. Qualitest Pharmaceuticals...
BioCentury | Oct 4, 2010
Financial News

Endo proposes equity-based line of credit

...has secured financing for up to $400 million in order to finance its acquisition of Qualitest Pharmaceuticals. WIR...
Items per page:
1 - 10 of 10
BioCentury | Feb 27, 2012
Finance

Cashing in on Qnexa

...strong growth in sales of generics as a result of its November 2010 acquisition of Qualitest Pharmaceuticals...
...from generics rose 131% to $151M and were driven by Endo's November 2010 acquisition of Qualitest Pharmaceuticals...
BioCentury | Oct 31, 2011
Finance

Finding love in Russia

...3Q10. Sales from generics rose 439% to $148M and were driven by the acquisition of Qualitest Pharmaceuticals...
BioCentury | Mar 7, 2011
Analyst Picks & Changes

Analyst picks & changes

...He believes the revenue increase largely is driven by the recent acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Feb 21, 2011
Strategy

Sweet Spot revisited

...Holdings Inc. sold $400 million in notes to help fund its acquisition of generics play Qualitest Pharmaceuticals...
BioCentury | Dec 6, 2010
Company News

Endo, Qualitest Pharmaceuticals deal

...billion in cash (see BioCentury, Oct. 4). Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP), Chadds Ford, Pa. Qualitest Pharmaceuticals...
BioCentury | Nov 22, 2010
Finance

Regulatory Milestones

...The company plans to use the proceeds to partially finance its acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Nov 20, 2010
Financial News

Endo raises $400M in note deal

...The company plans to use the proceeds to partially finance its acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Nov 16, 2010
Financial News

Endo planning $400M note deal

...company plans to use the proceeds to partially finance its ongoing acquisition of generics company Qualitest Pharmaceuticals...
BioCentury | Oct 4, 2010
Company News

Endo Pharmaceuticals Holding Inc., Qualitest Pharmaceuticals deal

...advised Endo and J.P. Morgan advised Qualitest. Endo Pharmaceuticals Holding Inc. (NASDAQ:ENDP), Chadds Ford, Pa. Qualitest Pharmaceuticals...
BioCentury | Oct 4, 2010
Financial News

Endo proposes equity-based line of credit

...has secured financing for up to $400 million in order to finance its acquisition of Qualitest Pharmaceuticals. WIR...
Items per page:
1 - 10 of 10